- Home
- BON vs AMIX Comparison
BON vs AMIX Comparison
Compare BON & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BON
- AMIX
- Stock Information
- Founded
- BON 2006
- AMIX 2014
- Country
- BON China
- AMIX United States
- Employees
- BON N/A
- AMIX N/A
- Industry
- BON Medicinal Chemicals and Botanical Products
- AMIX
- Sector
- BON Health Care
- AMIX
- Exchange
- BON Nasdaq
- AMIX NYSE
- Market Cap
- BON 6.6M
- AMIX 7.3M
- IPO Year
- BON 2021
- AMIX N/A
- Fundamental
- Price
- BON $1.42
- AMIX $2.99
- Analyst Decision
- BON
- AMIX
- Analyst Count
- BON 0
- AMIX 0
- Target Price
- BON N/A
- AMIX N/A
- AVG Volume (30 Days)
- BON 36.1K
- AMIX 971.1K
- Earning Date
- BON 02-07-2025
- AMIX 02-11-2025
- Dividend Yield
- BON N/A
- AMIX N/A
- EPS Growth
- BON N/A
- AMIX N/A
- EPS
- BON 2.22
- AMIX N/A
- Revenue
- BON $25,555,939.00
- AMIX N/A
- Revenue This Year
- BON $47.04
- AMIX N/A
- Revenue Next Year
- BON $77.63
- AMIX N/A
- P/E Ratio
- BON $0.63
- AMIX N/A
- Revenue Growth
- BON N/A
- AMIX N/A
- 52 Week Low
- BON $1.23
- AMIX $2.55
- 52 Week High
- BON $6.00
- AMIX $152.00
- Technical
- Relative Strength Index (RSI)
- BON 42.33
- AMIX 41.50
- Support Level
- BON $1.30
- AMIX $2.55
- Resistance Level
- BON $1.70
- AMIX $3.33
- Average True Range (ATR)
- BON 0.13
- AMIX 0.36
- MACD
- BON -0.04
- AMIX 0.18
- Stochastic Oscillator
- BON 32.13
- AMIX 41.32
About BON Bon Natural Life Limited
Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from perfumes and fragrance products.
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.